Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously

Journal of Clinical Investigation

Volumn 91, Issue 2, 1993, Pages 391-396

  Kupfer, Stuart R ^a   Underwood, Louis E ^a   Baxter, Robert C ^b   Clemmons, David R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Anabolism; Glucose regulation; Growth hormone; Insulin; Insulin like growth factor I

Indexed keywords

C PEPTIDE; GLUCOSE; GROWTH HORMONE; HUMAN GROWTH HORMONE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; UNCLASSIFIED DRUG; YNUTROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; GLUCOSE METABOLISM; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INTRAVENOUS DRUG ADMINISTRATION; METABOLIC REGULATION; NITROGEN BALANCE; NORMAL HUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; CARRIER PROTEINS; DRUG SYNERGISM; FEMALE; GLUCOSE; GROWTH HORMONE; HUMAN; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH-FACTOR-BINDING PROTEINS; MALE; MIDDLE AGE; NITROGEN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027533214     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI116212     Document Type: Article

References (40)

1. Waterlow, J. C., M. Golden, and D. Picou. 1977. The measurement of rales of protein turnover, synthesis, and breakdown in man and the effects of nutritional status and surgical injury. Am. J. Clin. Nutr. 30:1333-1339.
2. Shaw, J. H. S., M. Wildbore, and R. R. Wolfe. 1986. Whole body protein kinetics in severely septic patients: the response to glucose infusion and total parenteral nutrition. Ann. Surg. 205:288-294.
3. Streat, S. J., A. H. Beddoe, and L. H. Graham. 1987. Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. J. Trauma. 27:262-266.
4. Ward, H. C., D. Halliday, and A. J. W. Sim. 1987. Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery. Ann. Surg. 206:56-61.
5. Horber, F. F., and M. W. Haymond. 1990, Human growth hormone prevents protein catabolic side effects of prednisone in humans. J. Clin. Invest 86:265-272.
6. Pape, G. S., M. Freidman, L. E. Underwood, and D. R. Clemmons. 1991. The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease. Chest. 99:1495-1500.
7. Snyder, D. K., D. R. Clemmons, and L. E. Underwood. 1988. Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis and body composition. J. Clin. Endocrinol Metab. 67:54-61.
8. Manson, J. McK., and D. W. Wilmore. 1986. Positive nitrogen balance with human growth hormone and hypocaloric intravenous feeding. Surgery (St. Louis). 100:188-197.
9. Dahn, M. S., M. P. Lange, and L. A. Jacobs. 1988. Insulin-like growth factor I production is inhibited in human sepsis. Arch. Surg. 123:1409-1414.
10. Belcher, H. J. C. R., D. Mercer, K. C. Judkins, S. Shalaby, S. Wise, V. Marks, and N. S. B. Tanner. 1989. Biosynthetic growth hormone in burned patients: a pilot study. Burns. 15:99-107.
11. Sherwin, R. S., G. A. Shulman, R. Hendler, A. B. Walesky, A. Belous, and W. Tamborlane. 1983. Effect of growth hormone on oral glucose tolerance and circulating metabolic fuels in man. Diabetologia. 24:155-161.
12. Guler, H. P., J. Zapf, E. Scheiwiller, and E. R. Froesch. 1988. Recombinant human insulin-like growth factor-I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc. Natl. Acad. Sci. USA. 85:4889-4893.
13. Walker, J. L., M. G. Ginalska-Malinowska, T. E. Romer, J. B. Pucilowska, and L. E. Underwood. 1991. Effects of the infusion of insulin-like growth-factor-I in a child with growth hormone insensitivity syndrome (Laron dwarfism). N. Engl. J. Med. 324:1483-1488.
14. Clemmons, D. R., A. Smith-Banks, and L. E. Underwood. 1992. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor (IGF-I) in humans. J. Clin. Endocrinol. Metab. 75:234-238.
15. Metropolitan Life Insurance Co. New Weight Standards for Men and Women. 1983. Stal. Bul. Metropol. Life Insurance Co. 64:2-9.
16. USDA Handbook No. 8. 1976. United States Department of Agriculture, Washington, DC.
17. Davenport, M. L., M. E. Svoboda, K. L. Koerber, J. J. Van Wyk, D. R. Clemmons, and L. E. Underwood. 1988. Serum concentrations of insulin-like growth factor II are not changed by short term fasting and refeeding. J. Clin. Endocrinol. Metab. 67:1231-1236.
18. Voina, S. J., L. E. Underwood, and J. J. Van Wyk. 1971. Failure of leucine, arginine and epinephrine to alter plasma insulin levels in vitro. Horm. Metab. Res. 3:127-128.
19. Busby, W. H., D. K. Snyder, and D. R. Clemmons. 1988. Radioimmunoassay of a 26,000 dalton plasma insulin-like growth factor binding protein: control by nutritional variables. J. Clin. Endocrinol. Metab. 67:1225-1230.
20. Clemmons, D. R., W. H. Busby, and D. K. Snyder. 1991. Variables controlling the secretion of insulin-like growth factor binding protein-2 in normal human subjects. J. Clin. Endocrinol. Metab. 73:727-733.
21. Baxter, R. C. 1990. Circulating levels and molecular distribution of the acid-labile (α) subunit of the high molecular weight insulin-like growth factor-binding protein complex. J. Clin. Endocrinol. Metab. 70:1347-1353.
22. Snyder, D. K., D. R. Clemmons, and L. E. Underwood. 1989. Dietary carbohydrate content determines responsiveness to growth hormone in energy-restricted humans. J. Clin. Endocrinol. Metab. 69:745-752.
23. Marcus, R., G. Butterfield, L. Holloway, L. Gilliland, D. J. Baylink, R. L. Hintz, and B. M. Sherman. 1990. Effects of short term administration of recombinant human growth hormone to elderly people. J. Clin. Endocrinol. Melab. 70:519-527.
24. Snyder, D. K., L. E. Underwood, and D. R. Clemmons. 1990. Anabolic effects of growth hormone in obese diet-restricted subjects are dose dependent. Am. J. Clin. Nutr. 52:431-437.
25. Zeigler, T. R., J. L. Rombeau, L. S. Young, Y. Fong, M. Marano, S. F. Lowry, and D. W. Wilmore. 1992. Recombinant human growth hormone enhances the metabolic efficacy of parenteral nutrition: a double-blind, randomized controlled study. J. Clin. Endocrinol. Metab. 74:865-873.
26. Stein, P. T. 1982. Nutrition and protein turnover: a review. J. Patenter. Enternal Nutr. 6:444-454.
27. Cohn, S. H., D. Vartsky, S. Yasumra, A. Sawitsky, I. Zanzi, A. Vaswani, and K. J. Ellis. 1980. Compartmental body composition based on total-body nitrogen, potassium, and calcium. Am. J. Physiol. 239:E524-530.
28. Guler, H. P., C. Schmid, J. Zapf, and E. R. Froesch. 1989. Effect of recombinant human insulin-like growth factor-I on insulin secretion and renal function in normal human subjects. Proc. Natl. Acad. Sci. USA. 86:2868-2872.
29. Binoux, M., and P. Hossenlopp. 1988. Insulin-like growth factor (IGF) and IGF-binding proteins: comparison of human serum and lymph. J. Clin. Endocrinol. Metab. 67:509-514.
30. Jacob, R., E. Barrett, G. Plewe, K.. D. Fagin, and R. J. Sherwin. 1989. Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. J. Clin. Invest. 83:1717-1723.
31. Fukagawa, N. K., K. L. Minaker, J. W. Rowe, M. N. Goodman, D. E. Matthews, D. M. Bier, and V. R. Young. 1985. Insulin-mediated reduction of whole body protein breakdown. Dose-response effects on leucine metabolism in postabsorptive men. J. Clin. Invest. 76:2306-2311.
32. Daughaday, W. H., A. P. Ward, A. C. Goldberg, B. Trivedi, and M. Kapadia. 1982. Characterization of somatomedin binding in human serum by ultracentrifugation and gel filtration. J Clin. Endocrinol. Metab. 55:916-921.
33. Baxter, R. C., and J. L. Martin. 1989. Structure of the M, 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity labeling. Proc: Natl. Acad. Sci. USA. 86:6898-6902.
34. Guler, H. P., J. Zapf, C. Schmid, and E. R. Froesch. 1989. Insulin-like growth factors I and II in healthy man: estimations of half-lives and production rates. Acta Endocrinol. (Copenh.) 121:753-758.
35. Zapf, J., C. Schmid, H. P. Guler, M. Waldvogel, C. Hauri, E. Futo, P. Hossenlopp, M. Binoux, and E. R. Froesch. 1990. Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein 2 during IGF-I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia. J. Clin. Invest. 86:952-961.
36. Clemmons, D. R., J. P. Thissen, M. Maes, J. M. Ketelslegers, and L. E. Underwood. 1989. Insulin-like growth factor-I (IGF-I) infusion into hypophysectomized or protein-deprived rats induces specific IGF-binding proteins in serum. Endocrinology. 125:2967-2972.
37. Zapf, J., C. Hauri, M. Wadlvogel, E. Futo, H. Hasler, K. Binz, H. P. Guler, C. Schmid, and E. R. Froesch. 1989. Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats. Proc. Natl. Acad. Sci. USA. 86:3813-3817.
38. Guler, H. P., J. Zapf, and E. R. Froesch. 1987. Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N. Engl. J. Med. 317:137-140.
39. Guler, H. P., K. U. Eckhardt, J. Zapf, C. Bauer, and E. R. Froesch. 1989. Insulin-like growth factor I increases glomerular filtration rate and renal plasma flow in man. Acta Endocrinol. 121:101-106.
40. Ho, K. Y., and A. J. Weissberger. 1990. The antinatriuretic action of biosynthetic human growth hormone in man involves activation of the renin-angiotensin system. Metabolism. 39:133-137.